文献速递糖尿病肥胖与代谢综合征

美国印第安人纵向血浆脂质组与2型糖尿病风险

Longitudinal Plasma Lipidome and Risk of Type 2 Diabetes in a Large Sample of American Indians With Normal Fasting Glucose: The Strong Heart Family Study.
PubMed 文献 · Diabetes Care · 2021-10-26

在Strong Heart Family Study中,对1958名空腹血糖正常的美国印第安人重复测定3907份空腹血浆样本,随访至16年;发现33种脂质基线水平升高与5年时2型糖尿病风险增加相关(OR每SD 1.50-2.85),其中21种亦与16年风险相关。脂质失调早于糖尿病多年出现。

要点

  • 基线33种脂质(含甘油三酯、甘油二酯、磷脂)升高与2型糖尿病风险增加相关。
  • 糖尿病前期即可观察到致风险脂质升高、保护性脂质降低的异常谱。
  • 568种脂质的纵向变化与2型糖尿病连续指标变化显著相关。

核心结论

  • 脂质失调在2型糖尿病发病多年前即出现,基线水平及纵向变化的分子脂质与传统危险因素之外的风险显著相关。

研究设计与样本

  • Strong Heart Family Study前瞻性队列,1958名空腹血糖正常的美国印第安人,两次检查间隔约5.5年,随访至16年,非靶向液相色谱-质谱重复测定3907份空腹血浆样本,混合效应logistic回归分析。

主要发现

  • 33种脂质基线水平升高与5年随访2型糖尿病风险增加显著相关,OR(每SD log2转换基线脂质)1.50-2.85。
  • 其中21种脂质亦与16年随访2型糖尿病风险相关。
  • 糖尿病前期中致风险脂质OR(每SD)1.30-2.19,保护性脂质OR 0.70-0.78。
  • 568种脂质的纵向变化与2型糖尿病连续指标变化显著相关。

关键数值与推荐

  • 多重检验采用错误发现率0.05控制。
  • 多变量分析识别出区分高危及低危组的独特脂质组特征。

临床怎么用

  • 提示血浆分子脂质或可用于美国印第安人2型糖尿病早期风险分层与早期干预靶点探索。

局限性

  • 研究对象为美国印第安人,结果外推至其他人群需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Comprehensive assessment of alterations in lipid species preceding type 2 diabetes (T2D) is largely unknown. We aimed to identify plasma molecular lipids associated with risk of T2D in American Indians. RESEARCH DESIGN AND METHODS: Using untargeted liquid chromatography-mass spectrometry, we repeatedly measured 3,907 fasting plasma samples from 1,958 participants who attended two examinations (∼5.5 years apart) and were followed up to 16 years in the Strong Heart Family Study. Mixed-effects logistic regression was used to identify lipids associated with risk of T2D, adjusting for traditional risk factors. Repeated measurement analysis was performed to examine the association between change in lipidome and change in continuous measures of T2D, adjusting for baseline lipids. Multiple testing was controlled by false discovery rate at 0.05. RESULTS: Higher baseline level of 33 lipid species, including triacylglycerols, diacylglycerols, phosphoethanolamines, and phosphocholines, was significantly associated with increased risk of T2D (odds ratio [OR] per SD increase in log2-transformed baseline lipids 1.50-2.85) at 5-year follow-up. Of these, 21 lipids were also associated with risk of T2D at 16-year follow-up. Aberrant lipid profiles were also observed in prediabetes (OR per SD increase in log2-transformed baseline lipids 1.30-2.19 for risk lipids and 0.70-0.78 for protective lipids). Longitudinal changes in 568 lipids were significantly associated with changes in continuous measures of T2D. Multivariate analysis identified distinct lipidomic signatures differentiating high- from low-risk groups. CONCLUSIONS: Lipid dysregulation occurs many years preceding T2D, and novel molecular lipids (both baseline level and longitudinal change over time) are significantly associated with risk of T2D beyond traditional risk factors. Our findings shed light on the mechanisms linking dyslipidemia to T2D and may yield novel therapeutic targets for early intervention tailored to American Indians.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Miao G, Zhang Y, Huo Z, et al. Longitudinal Plasma Lipidome and Risk of Type 2 Diabetes in a Large Sample of American Indians With Normal Fasting Glucose: The Strong Heart Family Study. Diabetes Care. 2021. PMID: 34702783. doi:10.2337/dc21-0451

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。